UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pfizer Korea’s sales dwindle in generic drug market
Pfizer Korea’s sales power is dwindling in the local generic drug market, a...
by So Jae-hyeon
|
2017-12-04 11:55
라인
4 drugs gain insurance coverage this month
Four pharmaceuticals said Friday their drugs would gain national coverage, ...
by Marian Chu
|
2017-12-01 17:54
라인
Sanofi faces safety issues with dengue vaccine, will reel back usage
Sanofi said Thursday its dengue vaccine might worsen the disease for those ...
by Marian Chu
|
2017-12-01 14:03
라인
Korea United wins patent suit against Daewoong
Korea United Pharmaceutical has won a patent lawsuit against Daewoong Pharm...
by So Jae-hyeon
|
2017-12-01 14:03
라인
Lung cancer therapy Tagrisso’s price cut by 96%
Lung cancer patients will be able to purchase Tagrisso at 340,000 won ($312...
by Marian Chu
|
2017-12-01 11:19
라인
Sexual scandal at Pfizer Korea belatedly uncovered
After hospitals came under fire for senior physicians’ sexual violence agai...
by Nam Doo-hyun
|
2017-11-30 16:29
라인
‘Treatment of atopic dermatitis enhances kids’ mental health’
A U.S. dermatology physician said atopic dermatitis treatments could affect...
by Park Gi-taek
|
2017-11-30 16:22
라인
Pfizer Korea’s arthritis treatment gets insurance benefits
Pfizer Korea said Thursday that its nonsteroidal anti-inflammatory drug (NS...
by Constance Williams
|
2017-11-30 11:03
라인
Nanomedicine market to grow rapidly: report
With researchers actively using nanotechnology to treat diseases, the nanom...
by Nam Doo-hyun
|
2017-11-29 16:47
라인
Takeda gets extension for marketing Lymphoma treatment
Takeda Pharmaceuticals Korea announced Tuesday that the European Medicines ...
by Constance Williams
|
2017-11-29 14:58
라인
Novartis Korea mired in sexual harassment scandal
Novartis Korea has been embroiled in a sexual harassment scandal, as a male...
by Park Gi-taek
|
2017-11-29 14:58
라인
GL PharmTech eyes on new drug development, production
GL PharmTech, a provider of drug formulations and delivery technologies for...
by So Jae-hyeon
|
2017-11-29 11:55
라인
Pneumonia added to adverse reactions of hepatitis B drug Viread
The government has received reports of adverse drug reactions, including pn...
by Lee Hye-seon
|
2017-11-28 16:07
라인
Sanofi begins clinical trial on Hanmi’s diabetes treatment
Hanmi Pharmaceutical said Tuesday that Sanofi would begin to conduct phase ...
by Lee Han-soo
|
2017-11-28 11:05
라인
Ministry renews ‘innovative’ certification for 3 pharmaceuticals
The Ministry of Health and Welfare said it has recertified three pharmaceut...
by Marian Chu
|
2017-11-27 14:59
라인
AbbVie to present phase 3 study on investigational leukemia drug
AbbVie said Thursday that the American Society of Hematology (ASH) accepted...
by Marian Chu
|
2017-11-27 12:14
라인
Celltrion joins local drugmakers to tap US generic market
Korea’s generic drug manufacturers are entering the U.S. pharmaceutical mar...
by So Jae-hyeon
|
2017-11-27 12:04
라인
SK Chemicals, Pfizer locked in patent dispute over pneumonia vaccine
Results from a patent dispute between SK Chemicals and Pfizer will be relea...
by Marian Chu
|
2017-11-24 16:23
라인
CGBIO’s bone graft selected as next-generational product
CGBIO said Friday its bone graft infused with a protein called rhBMP-2, Nov...
by Marian Chu
|
2017-11-24 13:27
라인
Otezla, oral treatment for psoriasis, lands in Korea
The Ministry of Food and Drug Safety on Monday approved the local sales of ...
by Lee Hye-seon
|
2017-11-24 11:53
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top